Clinical trial
Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients With Graves' Orbitopathy
NCT03667157 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients With Graves' Orbitopathy
- Lead sponsor
- Medical University of Warsaw
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2012
- Completion date
- October 30, 2016
- Enrollment
- 68 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute liver failure, acute liver injury, acute liver injury, drug induced, dysthyroid ophthalmopathy, dysthyroid orbitopathy, glucocorticoids toxicity, graves disease, graves ophthalmopathy, liver diseases, liver dysfunction, liver failure, liver injury, liver insufficiency, methylprednisolone adverse reaction